Other MRI-based clinical radiological correlations have already been demonstrated to distinguish PSP, MSA-P, and PD [34] and for PSP, early diagnostic accuracy could be improved using a combination of cerebrospinal fluid (CSF) tau ratio and brainstem atrophy [35]. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.